Feeds:
Posts
Comments

Archive for April, 2010

*****

TODAY’S NEWS

Merck, Schering, Merger, Management, Munificence – it pays to be an exec at an acquired pharmaco.

What’s on the the docket for biotechs in the coming quarter? A nice, quick summary.

Kids’ suicide risk appears to be level across all anti-depressants. Now:  what about the risk of untreated depression??

RECOMMENDED

Software training – Do your employees need training on software programs? The Impactiviti Partner Network is your resource if you’re looking for a great provider.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Plus: What’s the Single Answer to Pharma’s biggest Digital Marketing Questions? I agree with Wendy Blackburn here.

JUST FOR FUN

Sand and Water. Some fabulous sand sculptures. Plus, eye-catching (even eerie) pictures of running water.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Read Full Post »

*****

TODAY’S NEWS

Hugely encouraging results for Novartis‘ new experimental (oral) MS treatment – Novartis’ Gilena has delivered an impressive performance in a Phase III trial in patients multiple sclerosis, cutting relapse rates by 62% in treatment-naïve patients and sustaining its effects for more than two years. Importantly, data from the two-year FREEDOMS study, presented at the American Academy of Neurology annual meeting, also showed that relapse rates were reduced by a significant 44% in patients who had previously been treated with other drugs for MS, highlighting the potential benefit of switching therapiesmore

Gilead starts late stage testing of “4-in-1″ HIV pill.

An interesting account of regulatory “unintended consequences.” How to make a cheap drug very expensive.

Cephalon hopes to gain more cheddar by adding some Swiss. Sorry – couldn’t resist…

Celgene: the new “big kid” on the block.

RECOMMENDED

Coaching Skills – The Impactiviti Partner Network is your resource if you’re looking to improve the coaching skills of your employees.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

An amusing patient health video made by J&J. Well worth 4 minutes of your time. The Appointment.

JUST FOR FUN

Oldie but goodie from The Onion – American to start charging fees to Non-passengers.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Read Full Post »

*****

Coming up on May 11th: BDI’s Social Communications & Healthcare event – half day session in NYC with Case Studies and Roundtables (I’ll be leading one of the roundtables). Top speakers from J&J, Pfizer, and more! These are always great networking and learning events. Hope to see you there!

For more information, including registration, please click here to visit the event website. Use promo code IMPACT for a discounted rate of $155.

TODAY’S NEWS

Lilly in an Indy pullback.

Taking another look at medical uses for hallucinogens. Timothy Leary would be proud!

Byetta (once-weekly) and possible cancer risks. Frankly, I have a bit of problem with this sort of stuff. When you pump rats with mega-doses of just about anything, what do you expect? Eternal life?

If you need a Monday morning dose of super-sized, complex words in a cloud of oncology verbiage, this one’s for you. Otherwise, nothing to see here…

RECOMMENDED

Selling Skills – We can recommend best-in-class partners and programs for your needs.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Letting Go.

JUST FOR FUN

Visual treat – Steel Giants floating on a blanket of Fog.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Read Full Post »

Upcoming Event

For more information, including registration, please click here to visit the event website. Use promo code IMPACT for a discounted rate of $155.

Date: Tuesday, May 11, 2010
Time: 8:00 a.m. – 1:00 p.m.
Location: The Graduate Center / CUNY; 365 Fifth Avenue; New York, NY 10016
Registration Fee: $195
Website: http://www.bdionline.com/socialhealthcare2010.html

About the Event:
Over the past year BDI has produced five programs focused on the impact of social communications on the healthcare industry. The 2nd annual Social Communications & Healthcare – Case Studies and Roundtables conference will demonstrate the best examples of how leading healthcare brands are accomplishing business objectives with social media and social networking. We will address the FDA’s position/role and what can be expected from future guidance. We will also explore how leading pharmaceuticals, medical technology companies, and hospital groups are integrating their social projects into their existing marketing, communications, education and service platforms.

The conference uses a proven half-day event format from 8:30 AM until 1:00 PM at The Graduate Center of The City University of New York in midtown Manhattan, New York City. The agenda will consist of several case study presentations in the general auditorium with 350+ attendees. The presentations will be followed by two moderated interactive roundtable discussion group sessions with 8-12 attendees each on very specific topics. We will also host a networking breakfast and networking breaks between sessions.

We will cover the following questions:

  • How do you deal with regulatory and legal issues when planning and implementing social media strategies
  • How do you connect with and tap into consumers who are already using the internet for healthcare information?
  • What are the case studies of leading brands that use internet based social strategies to achieve communications objectives?
  • What are examples of social communities that demonstrate how leading healthcare brands interact, educate, and provide value to consumers online?
  • Why real-time social media tools such as Twitter are gaining momentum and what’s the business case to use them?
  • How has social media impacted crisis communications specifically for the healthcare industry?
  • How do you sell social communications projects and prove ROI to senior management?
  • How do you create effective partnerships with new healthcare media leaders beyond advertising?
  • What are the best examples of how to use social communications to connect internally with employees and stakeholders?
  • What are the tools, technologies, and best practices for monitoring and measuring social communications?

We have a very limited amount of sponsorship/speaking opportunities available. BDI also produces customized webinars for sponsors who want to engage communications and marketing leaders. For more information please contact Steve Etzler at setzler@bdionline.com or 212-765-8045. Follow us on twitter at www.twitter.com/bdionline.

BDI is proud to have Jonathan Richman of Dose of Digital
announce the winners of The Dosie Awards!

Case Studies Presenters and Moderators:
Ann Aiken, Health Communications Specialist, Center for Disease Control (CDC)
Jarvis Cromwell, Managing Principal, Reputation Garage
Michael Fleming, Senior Director, Social Media, GlaxoSmithKline
Robert Halper, Director of Video Communication, Johnson & Johnson
Lance Hill, CEO, Within3
Brian Kaufman, Senior Director Client Solutions, KIT digital, Inc.
Ira Kaufman, Integrated Marketing Strategist, Entwine Inc.
Ray Kerins, Vice President / Worldwide Communications, Pfizer Inc.
Alan Levy, CEO, BlogTalkRadio
Marc Monseau, Director, Corporate Communications & Social Media, Johnson & Johnson
Mario Nacinovich, Editor-in-Chief, Journal of Communication in Healthcare
Jonathan Richman, Director of Strategic Planning, Bridge Worldwide & Author, Dose of Digital
Alex Romanovich, Founder, Chief Marketing Officer, Social2B
Nancy Shenker, Founder & CEO, theONswitch
Brian Simpson, Assistant Director Food & Beverage and Social Hospitality, The Roger Smith Hotel
Bill Sobel, Chief Connections Officer, SobelMedia LLC
Alicia Staley, The Staley Foundation
Patsy Stewart, Director Social Media Marketing & Training, Entwine Inc.
Steve Woodruff, Founder and President, Impactiviti

Hotel Sponsor: The Roger Smith Hotel Use promo code BDI10 to receive 10% off rate.

Sponsors:
PR Newswire / MultiVu; Ketchum; LiveWorld; Within3KIT digital, Inc.; BlogTalkRadio; Impactivity; ipTV Evangelist Maney Publishing: Journal of Communication in Healthcare; LatinVision; Mashable; Pharma Marketing NewsReputation Garage; SobelMedia; Social2B; Social Media & The Big WtheONswitch; What’s Next Blog

For more information, including registration, please click here to visit the event website. Use promo code IMPACT for a discounted rate of $155.

Read Full Post »

*****

Coming up on May 11th: BDI’s Social Communications & Healthcare event – half day session in NYC with Case Studies and Roundtables (I’ll be leading one of the roundtables). Top speakers from J&J, Pfizer, and more! These are always great networking and learning events. Hope to see you there!

For more information, including registration, please click here to visit the event website. Use promo code IMPACT for a discounted rate of $155.

TODAY’S NEWS

In Celgene‘s pipeline – a promising oral RA (Rheumatoid Arthritis) treatment – Celgene Corp. believes sales of lead development candidate Apremilast will be $2 billion to $3 billion a year in psoriasis and psoriatic arthritis. The drug, which would compete with some of the world’s biggest selling therapies, is expected to enter late-stage trials this year and could be launched in 2014 or 2015, the company said. The projection came during the Summit, N.J., drug maker’s research and development presentation in New York Thursdaymore But, not such good news about low-dose aspirin as a RA preventative.

Oh, by the way – there were a few suicides, too. How not to get approval for Daxas (Forest Labs).

The arguments begin the Novartis discrimination lawsuit. How many isolated incidents indicate a systemic problem? This one’s going to get sticky…

Letting Go. A challenge to think differently.

RECOMMENDED

Diversity/Ethics training– We can recommend best-in-class partners and programs for your needs.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

“Compulsive Generosity” due to Parkinson’s Rx – an embezzler gets off with an imaginative “the drug made me do it” plea. Ludicrous.

JUST FOR FUN

The Enlightened Stupid Marketer. 3 1/2 minutes of fun with Kevin Nalts.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Read Full Post »

*****

TODAY’S NEWS

Great news for hepatitis C treatment (and Vertex) – Adding the investigational drug telaprevir to standard treatment for hepatitis C infection cures about half the patients willing to give therapy a second try. That compares to a cure rate of just 14 percent among those who were retreated with the standard regimen, according to researchers at the Duke Clinical Research Institute (DCRI)more

Teva gets approval to market generic versions of two key Merck cardio drugs (Cozaar and Hyzaar).

Sanofi makes a long-term investment into a cool-sounding diabetes treatment (pre-Phase 1).

Is Nuvaring a pinata for plaintiff’s attorneys? – Merck’s Nuvaring contraceptive appears to be headed for the same fate as Bayer’s Yaz pill and Johnson & Johnson’s Ortho Evra contraceptive patch: It’s becoming a pinata for plaintiffs’ lawyers who allege the device is more dangerous than older, equally effective products on the marketmore

RECOMMENDED

eMarketing/PR– We can recommend best-in-class partners/agencies for your needs.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Social Media – Nine things Pharma should learn about Social Media from Dennis Urbaniak (of Sanofi-Aventis US). And, the finalists for the first Dosie Awards are announced.

JUST FOR FUN

Did you know that Niagara Falls once ran dry? True!

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Read Full Post »

*****

TODAY’S NEWS

Abbott Labs: Minus 175 – Abbott laid off approximately 175 sales reps in the US, Dow Jones reported yesterday. The company “shifted resources” within its US pharma business, and layoffs were not related to a specific brand…more

AstraZeneca and a winning strategy to get lawsuits dismissed (Seroquel tie to diabetes) – The drugmaker has used a similar strategy — questioning expert witness’ qualifications and whether plaintiffs have strong evidence that Seroquel caused their diabetes — to get numerous other lawsuits over the drug dismissed….more

FDA, Forest Labs, and Daxas for COPD – could be rough ride.

RECOMMENDED

eSolutions – Social Media/eMarketing. Learning Management. On-line testing. eLearning. You name it, we can recommend best-in-class partners for it.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

What does a sunrise in Virginia Beach look like? This, perhaps!

JUST FOR FUN

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Read Full Post »

« Newer Posts - Older Posts »

Follow

Get every new post delivered to your Inbox.

Join 27 other followers